Dow Up 0.76% Nasdaq Up 0.69%

Gilead Sciences Inc. (GILD)

-NasdaqGS
110.71 Up 3.53(3.29%) Oct 24, 4:00PM EDT
|After Hours : 111.00 Up 0.29 (0.26%) Oct 24, 7:56PM EDT
Prev Close:107.18
Open:107.34
Bid:109.81 x 500
Ask:N/A
1y Target Est:118.08
Beta:0.98
Next Earnings Date:28-Oct-14GILD Earnings announcement
Day's Range:106.60 - 111.47
52wk Range:63.50 - 111.47
Volume:15,130,759
Avg Vol (3m):14,395,200
Market Cap:167.36B
P/E (ttm):25.08
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
GILDUp 3.29%167.36B
GSKUp 0.95%109.99B
PFEUp 1.78%184.58B
RHHBYDown 0.19%248.56B

Key Statistics

Forward P/E (1 yr):11.47
P/S (ttm):9.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.05
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback